Double-blind, placebo-controlled (P), comparison of enoximone (E) and dobutamine (D) infusions in moderate to severe congestive heart failure patients (NYHA III–IV)

Double Blind ◽

Double Blind Placebo ◽

Heart Failure Patients

A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failure

American Heart Journal ◽

10.1016/0002-8703(92)90752-h ◽

1992 ◽

Vol 123 (1) ◽

pp. 95-103 ◽

Cited By ~ 34

Author(s):

Stuart D. Katz ◽

Spencer H. Kubo ◽

Mariell Jessup ◽

Suzanne Brozena ◽

Janice M. Troha ◽

...

Keyword(s):

Heart Failure ◽

Controlled Trial ◽

Double Blind ◽

1031-35 Value of Ibopamine as Adjunct to Maximal Oral Medication in Patients with Moderately Severe Congestive Heart Failure; a Double-Blind, Placebo-controlled Study

Journal of the American College of Cardiology ◽

10.1016/0735-1097(95)93190-n ◽

1995 ◽

Vol 25 (2) ◽

pp. 417A

Author(s):

Balázs M. Szabó ◽

Dirk J. van Veldhuisen ◽

Pieter H. van der Burgh ◽

Joost Kruik ◽

K.I. Lie

Keyword(s):

Heart Failure ◽

Oral Medication ◽

Controlled Study ◽

Double Blind ◽

Central and regional hemodynamic effects of oral enoximone in congestive heart failure: A double-blind, placebo-controlled study

American Heart Journal ◽

10.1016/0002-8703(88)90076-2 ◽

1988 ◽

Vol 115 (5) ◽

pp. 1051-1059 ◽

Cited By ~ 20

Author(s):

Carl V. Leier ◽

John J. Lima ◽

Steffen E.L. Meiler ◽

Donald V. Unverfeth

Keyword(s):

Heart Failure ◽

Controlled Study ◽

Hemodynamic Effects ◽

Double Blind ◽

Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.

Circulation ◽

10.1161/01.cir.79.3.491 ◽

1989 ◽

Vol 79 (3) ◽

pp. 491-502 ◽

Cited By ~ 153

Author(s):

H Drexler ◽

U Banhardt ◽

T Meinertz ◽

H Wollschläger ◽

M Lehmann ◽

...

Keyword(s):

Heart Failure ◽

Controlled Trial ◽

Converting Enzyme ◽

Long Term Effects ◽

Short Term ◽

Double Blind ◽

Double Blind Placebo ◽

Converting Enzyme Inhibition

A randomised, double‐blind, placebo‐controlled trial of metformin on myocardial efficiency in insulin‐resistant chronic heart failure patients without diabetes

European Journal of Heart Failure ◽

10.1002/ejhf.1656 ◽

2019 ◽

Vol 22 (9) ◽

pp. 1628-1637 ◽

Cited By ~ 8

Author(s):

Anders Hostrup Larsen ◽

Niels Jessen ◽

Helene Nørrelund ◽

Lars Poulsen Tolbod ◽

Hendrik Johannes Harms ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Heart Failure Patients ◽

Insulin Resistant ◽

Myocardial Efficiency

A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan®) in the treatment of patients with congestive heart failure NYHA II

Phytomedicine ◽

10.1078/0944-7113-00312 ◽

2003 ◽

Vol 10 (5) ◽

pp. 363-369 ◽

Cited By ~ 53

Author(s):

F.H. Degenring ◽

A. Suter ◽

M. Weber ◽

R. Saller

Keyword(s):

Heart Failure ◽

Clinical Trial ◽

Controlled Clinical Trial ◽

Double Blind ◽

Safety and Efficacy of Sertraline for Depression in Patients with CHF (SADHART-CHF): A randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure

American Heart Journal ◽

10.1016/j.ahj.2008.05.003 ◽

2008 ◽

Vol 156 (3) ◽

pp. 437-444 ◽

Cited By ~ 65

Author(s):

Wei Jiang ◽

Christopher O'Connor ◽

Susan G. Silva ◽

Maragatha Kuchibhatla ◽

Michael S. Cuffe ◽

...

Keyword(s):

Heart Failure ◽

Major Depression ◽

Controlled Trial ◽

Double Blind ◽

Safety And Efficacy ◽

Effect of thyroid hormone supplementation on survival of euthyroid dogs with congestive heart failure due to systolic myocardial dysfunction: a double-blind, placebo-controlled trial

Research in Veterinary Science ◽

10.1016/s0034-5288(03)00111-5 ◽

2003 ◽

Vol 75 (3) ◽

pp. 195-201 ◽

Cited By ~ 6

Author(s):

Anna Tidholm ◽

T Falk ◽

S Gundler ◽

H Svensson ◽

B Åblad ◽

...

Keyword(s):

Heart Failure ◽

Thyroid Hormone ◽

Myocardial Dysfunction ◽

Controlled Trial ◽

Double Blind ◽

16.1 Treatment cost in Canada of severe congestive heart failure patients

EP Europace ◽

10.1016/eupace/4.supplement_1.a27 ◽

2003 ◽

Vol 4 (Supplement_1) ◽

pp. A27-A27

Author(s):

S. Lepage ◽

P. Liu ◽

J.D. Bentkover ◽

A. Ignaszewski

Keyword(s):

Heart Failure ◽

Treatment Cost ◽

Heart Failure Patients

Efficacy and Safety of Tolvaptan in Heart Failure Patients with Volume Overload Despite the Standard Treatment with Conventional Diuretics: A Phase III, Randomized, Double-blind, Placebo-controlled Study (QUEST Study)

Cardiovascular Drugs and Therapy ◽

10.1007/s10557-011-6304-x ◽

2011 ◽

Vol 25 (S1) ◽

pp. 33-45 ◽

Cited By ~ 91

Author(s):

Masunori Matsuzaki ◽

◽

Masatsugu Hori ◽

Tohru Izumi ◽

Masatake Fukunami

Keyword(s):

Heart Failure ◽

Standard Treatment ◽

Volume Overload ◽

Phase Iii ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Heart Failure Patients